What is InfoBionic.Ai?
InfoBionic.Ai is a Massachusetts-based healthcare technology firm dedicated to transforming the economics and operational efficiency of remote patient monitoring. The company specializes in the development of sophisticated diagnostic tools, most notably the MoMe Kardia device, which is engineered to streamline the detection and monitoring of cardiac arrhythmias. By bridging the gap between complex medical device engineering and mobile technology, InfoBionic.Ai provides physicians with actionable data, thereby reducing the diagnostic roadblocks that have historically hindered effective patient care. The firm operates at the intersection of medical device innovation and health information technology, targeting a critical need for more responsive, data-driven cardiology solutions in an increasingly ambulatory healthcare environment.
How much funding has InfoBionic.Ai raised?
InfoBionic.Ai has raised a total of $70.7M across 7 funding rounds:
Other Financing Round
$1M
Private Equity
$969K
Other Financing Round
$1.2M
Series B
$8.2M
Unspecified
$50M
Debt
$350K
Debt
$9M
Other Financing Round (2012): $1M with participation from Broadview Ventures
Private Equity (2012): $969K led by Undisclosed
Other Financing Round (2013): $1.2M supported by Cherrystone Angel Group
Series B (2015): $8.2M featuring Zaffre Investments, Safeguard Scientifics, and Excel Venture Management
Unspecified (2018): $50M backed by Excel Venture Management, Blue Cross and Blue Shield of Kansas, Zaffre Investments, Safeguard Scientifics, and Eagle Investments
Debt (2020): $350K with participation from PPP
Debt (2021): $9M led by Horizon Technology Finance
Key Investors in InfoBionic.Ai
Zaffre Investments
A subsidiary of Blue Cross Blue Shield of Massachusetts, this firm focuses on healthcare innovation, including health information technology and consumer solutions, providing strategic direction and industry connections.
Safeguard Scientifics
A long-standing venture capital and private equity firm that provides capital and operational expertise to fuel the growth of technology-driven businesses in the healthcare and financial services sectors.
Excel Venture Management
A venture capital firm specializing in early-stage and growth-stage investments within the life sciences and healthcare technology industries.
What's next for InfoBionic.Ai?
Looking ahead, InfoBionic.Ai is poised to leverage its recent capital influx to accelerate the commercial adoption of its remote monitoring ecosystem. The company's strategic roadmap likely involves expanding its footprint within the cardiology market, enhancing the analytical capabilities of its software suite, and deepening its integration with existing clinical workflows. Given the firm's history of securing support from specialized healthcare investors, the focus will remain on scaling operations while maintaining the high clinical standards required for cardiac diagnostic devices. As the healthcare industry continues to shift toward value-based care models, InfoBionic.Ai's ability to provide cost-effective, high-utility monitoring solutions will be a primary driver of its long-term competitive advantage and market penetration.
See full InfoBionic.Ai company page
